Navigation Links
Michael Berman Joins InspireMD Board
Date:2/11/2013

eptance and general use in time-critical emergency settings.

About InspireMD, Inc.

InspireMD is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard™. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is quoted on the OTC under the ticker symbol NSPRD.

About MGuard Embolic Protection Coronary Stent

MGuard EPS combines a coronary stent merged with an embolic protection specifically designed for acute MI patients. The embolic protection is comprised of an ultra-thin polymer micron net that is integrated with the stent. The MGuard EPS is designed to provide outstanding and lifelong embolic protection, without affecting deliverability.

Forward-looking Statements:

This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multi-national companies, (v) product liability claims, (vi) our limited manufacturing capabi
'/>"/>

SOURCE Inspire MD
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. Michael Cusumano, MITs Sloan Distinguished Professor of Management, Joins Quantum Leap Innovations Board of Directors
3. Michael A. Marletta Takes Office as New President of Scripps Research Institute
4. NeuroPhage Receives Michael J. Fox Foundation Funding for Parkinsons Disease Research
5. WestPark Capitals Michael Wechsler Comments on the Life Insurance Market
6. Campbell Alliance Launches Market Research and Analytics Group, Appoints Michael Turner as General Manager of Encuity Research
7. Music Legend And Health Advocate Bret Michaels To Address Diversity Alliance For Science 2012 National Conference And EXPO
8. 2011-2012 Michael E. DeBakey Journalism Award Winners Announced
9. Dr. Michael Yaremchuk, Leading Performer of Custom-Designed Facial Implants, Pioneers Bespoke Plastic Surgery
10. Sigma-Aldrich Elects Michael Marberry As Director
11. Amarantus BioSciences Updates Shareholders on Timing of Michael J. Fox Foundation Grant Data Release
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 4, 2015 Launched by ... in December 2011, ,SARAH, - the ... microspheres versus sorafenib in advanced hepatocellular carcinoma (HCC) has ...   SARAH, a large French study of ... or HCC) has completed patient enrolment, exceeding its 400-patient ...
(Date:3/3/2015)... DIEGO , March 3, 2015  Halozyme Therapeutics, Inc. ... Barclays 2015 Global Healthcare Conference in Miami, FL ... a.m. PT. David A. Ramsay , Chief Financial Officer, ... be webcast through the "Investors" section of Halozyme,s corporate website ... available for 90 days following the event. To access the ...
(Date:3/3/2015)... Mar. 03, 2015 Research and Markets ... "Gene Therapy Market, 2015 - 2025" report ... Market, 2015-2025" report provides an extensive study on the ... has been carried out in this field for over ... (four available in Asian markets; one approved in the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... Inc. to their international sales network. The business ... dissolution technology to Canada’s Atlantic Provinces, exclusively through ... served as one of Canada’s premiere manufacturing representative ... both the municipal water and wastewater markets. More ...
Breaking Biology Technology:Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 2Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 3Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 4Treatment of Primary Liver Cancer: SARAH Study Completes Enrolment, Results Expected Late 2016 5Halozyme Therapeutics To Present At The Barclays 2015 Global Healthcare Conference 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 2Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 3Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 4Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 5Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 6Global Gene Therapy Market Report 2015-2025 - Extensive Study on the Marketed and Pipeline Gene Therapies 7BlueInGreen® Continues Canadian Expansion, Partners with Resource Systems Inc. 2
... Advanced Life Sciences Holdings, Inc. ... the discovery, development and commercialization of novel drugs in the ... that the Company has entered into a debt for equity ... Flavin , Ph.D.  Under the terms of the agreement, the ...
... LONDON , July 22, 2010 ... discovery and development, is,pleased to announce that it has augmented the strength ... DeCherney and Munir,Pirmohamed . With their extensive clinical, healthcare, and ... , , ...
... , July 21 Responding to a lack of voter ... bio-medical pioneer and mega-entrepreneur, today announced his intention to conduct a write-in ... , ... of Bioheart Inc., a biotechnology company, and owner of Leonhardt Vineyards ( ...
Cached Biology Technology:Advanced Life Sciences CEO Acquires $2 Million of Common Stock Through Debt for Equity Exchange 2Advanced Life Sciences CEO Acquires $2 Million of Common Stock Through Debt for Equity Exchange 3London Genetics Expands its Senior Advisory Team 2London Genetics Expands its Senior Advisory Team 3London Genetics Expands its Senior Advisory Team 4Howard J. Leonhardt Announces Candidacy for Governor of California 2Howard J. Leonhardt Announces Candidacy for Governor of California 3Howard J. Leonhardt Announces Candidacy for Governor of California 4
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
(Date:2/9/2015)...  Lintec of America recently announced an exclusive license ... macrostructures, including sheets, yarns and ribbons, developed at the ... the vast industrial resources of the global Lintec Group, ... of America is forming the Nano-Science and Technology Center ... on scaling up the manufacturing and commercialization of nano ...
(Date:2/5/2015)... , Feb. 5, 2015  Marken is starting ... company and has launched a new marketing campaign to ... Organization (CLO).  The new campaign focuses on First ... protocol and shipments. The first headline in ... aligns Marken,s priorities with its client,s priorities. Marken recognizes ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4Marken Launches New Patient-Centric Campaign 2
... Maine Toxicity (GOMTOX) project issued an outlook for a significant ... tides, in the spring and summer of this year, potentially ... seed population in bottom sediments has set the stage for ... This organism swims in the water, and divides again and ...
... Bacteria in Cattle Manure May Survive Composting ... may actually survive the composting process. Researchers from Agriculture ... of the journal Applied and Environmental Microbiology ... and persist for long periods in the final product. ...
... The squirrels littering your lawn with acorns as they bound ... ones that aerate it with their burrows, according to a ... that flying birds and bats live longer than earthbound animals ... candidates in anthropology, decided to take a closer look at ...
Cached Biology News:Researchers issue outlook for a significant New England 'red tide' in 2010 2Researchers issue outlook for a significant New England 'red tide' in 2010 3Tips from the Journals of the American Society for Microbiology 2Tips from the Journals of the American Society for Microbiology 3Tips from the Journals of the American Society for Microbiology 4Tree-dwelling mammals climb to the heights of longevity 2
Excellent safety and durability., Remote control can be easily operated in your hand., Constant voltage control with 2 sets of terminals., Precise and durable circuit design. ...
Gel Loading Buffer contains a precipitant to ensure that the samples sink into the wells and a tracking dye to allow the user to follow the progress of electrophoresis....
Rabbit anti Xanthine Oxidase Xanthine Oxidase, Bovine Buttermilk...
Mouse polyclonal antibody to QPRT - quinolinate phosphoribosyltransferase (nicotinate-nucleotide pyrophosphorylase (carboxylating))...
Biology Products: